Onomi

The debate made one thing clear: the real opportunity at medical congresses is in the digital layer that surrounds every in-person interaction. Pierre Metrailler noted that participants experience around 150 touch points, and pharma can influence only a few. Those moments must be created intentionally at the booth, in symposia, and in meetings. When teams structure and capture those touch points digitally, congresses become measurable and repeatable. Watch the full debate on demand. https://lnkd.in/gV-eJXk4

Fad or trend? Robert Tegge, Associate Principal at ZS spends his time in pharma congress programs. Pierre Metrailler, our CEO, spends his time building the infrastructure that connects those congresses to CRM. They see the same pattern: a few teams are using congresses as real engagement engines. Most are still trying to explain why they cannot prove ROI. Tomorrow, they will break down the five congress trends that will shape 2026…or not. They will cover what actually changed in 2025, which ideas are fading, how to separate trends from fads, and the three bets for next year. Join them live and weigh in on what you consider a game-changer or what will soon be a thing of the past. https://lnkd.in/gG7cZ6kA

Are congresses still worth the investment? That question drove “The Great Debate,” where four leaders tested opposing views against real data and real HCP expectations. Insights from IPCAA show HCPs want simple follow-through: slides, clarity on scientific content, and relevant post-congress next steps. Pierre Metrailler and Jo Cowler argued these expectations still make congresses essential anchors for scientific exchange. Watch the full debate on demand: https://lnkd.in/gV-eJXk4

Medical congresses are broken. $100M budgets. Little proven ROI. And everyone’s throwing AI at the problem like it’s 2019. On December 4, Robert Tegge from ZS and Pierre Metrailler will dissect what’s actually happening at congresses. Not the “digital transformation” theater. The real shifts that separate winners from “we’re still figuring out our KPIs” teams. If your congress reports still start with activity counts instead of insight and impact, this session is for you. Register now. https://lnkd.in/gG7cZ6kA

Are medical congresses still worth the investment? In a recent debate, leaders from medical, commercial, and digital teams challenged assumptions with data. Pierre Metrailler argued that congresses remain one of the few moments where HCP attention, scientific relevance, and industry presence converge. Panelists from BMS, MAPS, Amgen, and Onomi, moderated by Paul Simms, shared what truly drives value. Watch the on-demand debate if you are reassessing your congress strategy. https://lnkd.in/gV-eJXk4

Five big ideas are shaping congress strategy for 2026. The question is whether they are real trends or short-lived fads. On December 4, Pierre Metrailler and Robert Tegge from ZS will break down the five shifts everyone is talking about and debate which ones will actually matter next year. Here is what they will put to the test: 👉Budget rationalization 👉The KOL engagement stack 👉Killing the KPIs 👉Splitting strategy from operations 👉AI that works This session is an open debate, not a presentation. You will weigh in on what you consider a game-changer or what will soon be a thing of the past. Register now. https://lnkd.in/gG7cZ6kA

In life sciences, webinars are done by default. But most still run on luck, slides, and a hope for engagement. That’s what Henrik Larssen set out to fix. By standardizing templates, uniting medical and commercial teams, and connecting webinar data directly into CRM, him and his team built a model that proved measurable impact. Not attendance. Impact. Join Henrik Larssen and Pierre Metrailler, CEO of Onomi, on November 13 as they unpack the journey from fragmented execution to a scalable, compliant, data-driven framework. What you’ll learn: - How to turn webinars into a repeatable go-to-market model - How to measure HCP learning and confidence (not just clicks) - How to sync engagement data into CRM for real next-best actions Register here: https://lnkd.in/gtTeu32X

Webinars were never meant to be one-off events. On November 13, Henrik Larssen (Global Omnichannel Lead) and Pierre Metrailler (Onomi CEO) will reveal how a global rare disease team turned webinars into a scalable go-to-market model that reached 40 markets, 1,400+ HCPs, and proved measurable impact. What you’ll learn: - How to build a repeatable webinar model that drives real engagement - How to measure HCP confidence as proof of impact - How to connect webinar data directly to CRM for next-best actions - How to scale execution globally while staying compliant and efficient Join the session and get all the details: https://lnkd.in/gtTeu32X

35 webinar registrations, 11 attended. Sound familiar? Most pharma webinar programs are stuck in this death spiral. They push harder on marketing automation. Send more emails. Get labeled as spam. Numbers keep dropping. Here is a fresh idea: *dual webinar amplification* The magic: combining push and pull in the same program Push: Open registration. Marketing automation. Standard outreach. LinkedIn ads, etc. Gets you volume. Pull: Direct rep invites with RSVP links. Personal context - it's RSVP, not just "fill in this form" + "Dr. Chen, thought this case we discussed would interest you." That second layer changes everything. It's not just another webinar invite - it's personalized with context. And the in-mail RSVP approach reduces registration abandonment. Results: higher registration rates, better attendance, and strong engagement. Your mileage may vary but it's just better. Henrik Larssen scaled a rare disease global webinar program to 40 markets. This Thursday, Henrik will be walking us through exactly how he built this dual model. Thursday, November 13th, 2025 4:00 PM CET / 10:00 AM ET - registration below

𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗗𝗮𝘁𝗮 𝗶𝘀 𝘁𝗵𝗲 𝗻𝗲𝘄 𝗚𝗼𝗹𝗱. It can be 𝘁𝘂𝗿𝗻𝗲𝗱 𝗶𝗻𝘁𝗼 𝗷𝗲𝘄𝗲𝗹𝗿𝘆 by adding your creativity and passion. “Capture It, Structure It and Act on It.” 𝗢𝗻 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟯, 𝟮𝟬𝟮𝟱 𝗮𝘁 𝟰:𝟬𝟬 𝗽𝗺(𝗖𝗘𝗧) 𝗮𝗻𝗱 𝟭𝟬:𝟬𝟬 𝗮𝗺 (𝗘𝗧) I have the pleasure of joining Pierre Metrailler at Onomi discussing learnings/insights of designing and executing a Webinar based Go To market model in the field of Rare Diseases. 𝗬𝗼𝘂 𝗰𝗮𝗻 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝘁𝗼 𝗮𝘁𝘁𝗲𝗻𝗱 𝗵𝗲𝗿𝗲:  https://lnkd.in/d-tuut7Q